After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Vaxcyte Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Vaxcyte Inc is $11.80B. A total of 0.81 million shares were traded on the day, compared to an average of 1.31M shares.
In the most recent transaction, GUGGENHIME ANDREW sold 8,000 shares of PCVX for 85.81 per share on Nov 18 ’24. After the transaction, the PRESIDENT AND CFO now owns 109,491 company shares. In a previous transaction on Nov 18 ’24, GUGGENHIME ANDREW bought 8,000 shares at 86.50 per share.
Among the insiders who sold shares, PICKERING GRANT disposed of 2,366 shares on Nov 07 ’24 at a per-share price of $103.89. This resulted in the CHIEF EXECUTIVE OFFICER holding 137,398 shares of PCVX after the transaction. In another insider transaction, PICKERING GRANT bought 2,366 shares at $104.08 per share on Nov 07 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PCVX has a high of $121.06 and a low of $48.81.
As of this writing, PCVX has an earnings estimate of -$1.04 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.96 per share and a lower estimate of -$1.15. The company reported an EPS of -$1.82 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PCVX’s latest balance sheet shows that the firm has $245.97M in Cash & Short Term Investments as of fiscal 2021. There were $16.78M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $27.47, while its Total Shareholder’s Equity was $284.02M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCVX is Buy with a score of 4.89.
